References
- Adlercreutz H, Fotsis T, Bammwart C, Wahala K, Makela T, Brunow G, Hase T. (1986a): Determination of urinary lig-nan and phytoestrogen metabolites, potential antiestrogen and anti-carcinogenens in urine of woman on various habitual diets. J Steroid Biochem 25: 791–797.
- Adlercreutz H, Musey P. L, Fotsis T, Barnmwart C, Wahala K, Makela T, Brunow G, Hase T. (1986b): Identification of ligans and phytoestrogens in urine of chimpanzees. Clin Chim Acta 158: 147–154.
- Ahmed ASE-D, Ahmed ME-L (1994): Effect of substitution pattern on the Rf value of fiavones. Alexandria J Pharm Sci 18: 7–10.
- Axelson M, Sjovall J, Gustafsson BE, Setchel KDR (1982): Origin of lignans in mammals and identification of a pre-cursor from plants. Nature 298: 659–660.
- Ayres DC, Loike, JD (1990): "Lignans: Chemical, biological and clinical properties", Chemistry and Pharmacology of Natural Products Series, Cambridge University Press, Cambridge, U.K. pp. 85–96.
- Bakke JE, Klosterman HJ (1956): A new diglucoside from flaxseed. Proc N Dakota Acad Sci 10: 18–21.
- Deschner EE, Ruperto J Wong G, Newmark HL (1991): Quercetin and rutin as inhibitors of azoxymethanol-induced colonlic neoplasia. Carcinogenesis 12: 1193.
- Fujita Y, Uehara I, Morimoto Y, Nakashima M, Hatano T, Okuda T (1988): Studies on inhibition mechanism of autoxidant by tannins and flavonoids. II. Inhibition mech-anism of caffeetannins isolated from leaves of Artemisia species on lipoxygenase depend lipid peroxidation. Yalcu-gaku Zasshi 108, 129–135.
- Hirano T, Fukuoka K, Oka K, Naito T, Hosaka K, Mituhashi H, Matsumoyo Y (1990): Antiproliferative activity of ligan derivatives against the human breast carcinoma cell line, ZR-75-1 Cancer Invest 8: 595–602.
- Jenab M, Thompson LU (1996): The influence of flaxseed and lignans on colon carcinogenesis and P-glucuronidase activity. Carcinogenesis 17: 1343–1348.
- Kahl R. (1991): Protective and adverse biological actions of phenolic antioxidants. In: Oxidative Stress: Oxidants and Antioxidants (Seies H ed), Academic Press, New York NY, pp. 245-273.
- Klyne W (1950): The configuration of the anomeric carbon atoms in some cardiac glycosides. Biochemistry 47: XII.
- Luyengi L, Pezzuto JM, Waller DP, Beecher CWVV, Fong HHS, Che C-T, Bowen PE (1993): Linusitamarin, a new phenylpropanoid glucoside from Linum usitatissimum. J Nat Prod 56: 2012–2015.
- Mabry TJ, Markham KR, Thomas MB (1970): The System-atic Identification of Flavonoids, Springer, Berlin.
- Markam KR, Ternai B, Stanley R, Geiger H, Mabry TJ (1978): Carbon-13 NMR spectroscopy of fiavonoids. Tetrahedron 34: 1389.
- Mousavi Y, Adlercreutz H (1992): Enterolactone and estra-diol inhibit each others's proliferative effect on MCF-7 breast cancer cells in culture. J Steroid Biochem Molec Bio141: 615–619.
- Nishibe S, Tsukamoto H, Hisdda S (1984): Effects of 0-methylation and 0-glucosylation on Carbon-13 nuclear magnetic resonance, chemical shifts of matairesinol, (+)-pinoresinol and (+)-epinoresinol. Chem Pharm Bull 32: 4653.
- Pezzuto JM (1995): Natural product cancer chemopreventive agents. In JT Arnanson, R Mata, and JT Romeo (eds.), Recent Advances in Phytochemisty, Vol 29. Phyto-chemistry of Medicinal Plants, pp. 19–45, New York: Plenum Press.
- Pezzuto JM, Beecher CWVV, Fong HHS, Farnsworth NR, Mehta RG, Moon RC, Hedayat S, Udeani GO, Moriarty RM, Kinghorm AD (1996): Discovery and characteriza-tion of natural product cancer chemopreventive agents. Proc 6th Intern Symposium on Natural Product Chem-istry, Karachi, Pakistan.
- Purev O, Pospisil F, Motl O (1988): Chemical study of Sida hermaphrodita. Coll Czech Chem Commun 53: 3193–3196.
- Richard SE, Orcheson LJ, Seidl MM, Luyengi L, Fong HHS, Thompson LU (1996): Dose-dependent production of mammalian lignans in rats and in vitro from the purified, precursor secoisolariciresinol diglucoside in flaxseed. J Nutr 126: 2012–2019.
- Serraino MR, Thompson LU (1991): The effect of flaxseed supplementation on early risk markers for mammary car-cinogenesis. Cancer Lett 60: 135–142.
- Serraino MR, Thompson LU (1992a): The effect of flaxseed supplementation on the initation and promotional stages of mammary tumorigenesis. Nutr Cancer 17: 153–159.
- Serraino MR, Thompson LU (1992b): Flaxseed supplemen-tation and early markers of colon carcinogenesis. Cancer Lett 63: 159–165.
- Shibuya H, Takeda Y, Zhang R-S, Tanitame A, Tsai YL, Kita-gawa 1(1992): Indonesian medicinal plants. IV. On the constituents of the bark of Fagara rhetza (Rutaceae) (2): Lignan glycosides and two apioglucosides. Chem Pharm Bull 40: 2639.
- Thompson LU, Rickard SE, Orcheson LJ, Seidl MM (1996b): Flaxseed and its lignan components reduce mammary tumor growth at a late stage of carcinogenesis. Carcinogenesis 17: 1373–1376.
- Thompson LU, Robb P, Serranio M, Cheung F (1991): Mam-malian lignan production from various foods. Nutr Cancer 16: 43–52.
- Thompson LU, Seidl MM, Rickard SE, Orcheson LJ, Fong HHS (1996a): Antitumorigenic effect of a mammalian lig–nan precursor from flaxseed. Nutr Cancer 26: 159–165.